Solid Biosciences logo

Solid Biosciences Share Price Today

(NASDAQ: SLDB)

Solid Biosciences share price is $5.76 & ₹501.49 as on 6 Mar 2025, 2.30 'hrs' IST

$5.76

0.45

(8.47%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Solid Biosciences share price in Dollar and Rupees. Guide to invest in Solid Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Solid Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Solid Biosciences share price movements

  • Today's Low: $5.23
    Today's High: $5.77

    Day's Volatility :9.32%

  • 52 Weeks Low: $2.88
    52 Weeks High: $15.05

    52 Weeks Volatility :80.86%

Solid Biosciences (SLDB) Returns

PeriodSolid Biosciences IncRussel 2000Index (Russel 2000)
3 Months
16.13%
0.0%
0.0%
6 Months
-32.31%
0.0%
0.0%
1 Year
-38.85%
0.0%
0.0%
3 Years
-48.46%
-11.6%
-11.6%

Solid Biosciences (SLDB) Key Statistics

in dollars & INR

Previous Close
$5.31
Open
$5.29
Today's High
$5.77
Today's Low
$5.232
Market Capitalization
$439.6M
Today's Volume
$1.1M
52 Week High
$15.05
52 Week Low
$2.88
Revenue TTM
$0.0
EBITDA
$-109.9M
Earnings Per Share (EPS)
$-3.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-65.79%

How to invest in Solid Biosciences Stock (SLDB) from India?

It is very easy for Indian residents to invest directly in Solid Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Solid Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Solid Biosciences or SLDB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Solid Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Solid Biosciences shares which would translate to 0.151 fractional shares of Solid Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Solid Biosciences, in just a few clicks!

Returns in Solid Biosciences (SLDB) for Indian investors in Rupees

The Solid Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Solid Biosciences investment value today

Current value as on today

₹66,211

Returns

₹33,789

(-33.79%)

Returns from Solid Biosciences Stock

₹38,854 (-38.85%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Solid Biosciences (SLDB)

191%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Solid Biosciences Stock from India on INDmoney has increased by 191% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Solid Biosciences

  • Perceptive Advisors LLC

    9.05%

  • RA Capital Management, LLC

    5.67%

  • Bain Capital Life Sciences Investors, LLC

    5.29%

  • Siren, L.L.C.

    4.91%

  • Vestal Point Capital LP

    3.73%

  • BlackRock Inc

    2.44%

Analyst Recommendation on Solid Biosciences

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Solid Biosciences(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
8
Hold
3
3
4
Sell
0
0
0

Analyst Forecast on Solid Biosciences Stock (SLDB)

What analysts predicted

Upside of 184.72%

Target:

$16.40

Current:

$5.76

Insights on Solid Biosciences Stock (Ticker Symbol: SLDB)

  • Price Movement

    In the last 1 month, SLDB stock has moved up by 84.0%
  • SLDB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 105.4%
  • SLDB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 100.6%

Solid Biosciences Technicals Summary

Sell

Neutral

Buy

Solid Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Solid Biosciences (SLDB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Solid Biosciences Inc logo
89.47%
-32.31%
-38.85%
-48.46%
-88.43%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Solid Biosciences Inc logo
0.15
NA
NA
-2.9
-0.66
-0.35
NA
4.29
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Solid Biosciences Inc logo
Buy
$439.6M
-88.43%
0.15
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Solid Biosciences

Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a gene transfer candidate for the treatment of Duchenne muscular dystrophy; and SGT-501 to treat Catecholaminergic polymorphic ventricular tachycardia. It is also developing AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy; SGT-601 to treat a rare cardiac disease characterized by mutations in the gene that codes for cardiac troponin T protein, which helps coordinate contraction of the heart muscle; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, a cardiac splicing factor that regulates alternative splicing, and codes for RNA binding motif protein 20; and AVB-202-TT to treat Friedreich's ataxia, as well as other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne; and a license agreement with the University of Washington, University of Missouri, and University of Florida. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.
Organization
Solid Biosciences
Employees
88
CEO
Mr. Alexander G. Cumbo
Industry
Health Technology

Management People of Solid Biosciences

NameTitle
Mr. Ian F. Smith A.C.A., C.P.A.
Executive Chair
Mr. Alexander G. Cumbo
President, CEO & Director
Mr. Ilan Ganot
Co-founder, Strategic Advisor to the CEO & Director
Mr. Kevin Tan C.F.A.
CFO & Treasurer
Mr. David Tyronne Howton Jr., J.D.
COO, General Counsel & Secretary
Ms. Annie Ganot
Co-Founder & Head of Patient Advocacy
Mr. Paul Herzich
Chief Technology Officer
Ms. Nicole Anderson
Director of Investor Relations & Corporate Communications
Ms. Allison Bogosian J.D.
Senior Vice President of Human Resources
Dr. Jessie Hanrahan Ph.D.
Chief Regulatory & Preclinical Operations Officer

Important FAQs about investing in SLDB Stock from India :

What is Solid Biosciences share price today?

Solid Biosciences share price today stands at $5.76, Open: $5.29 ; Previous Close: $5.31 ; High: $5.77 ; Low: $5.23 ; 52 Week High: $15.05 ; 52 Week Low: $2.88.

The stock opens at $5.29, after a previous close of $5.31. The stock reached a daily high of $5.77 and a low of $5.23, with a 52-week high of $15.05 and a 52-week low of $2.88.

Can Indians buy Solid Biosciences shares?

Yes, Indians can invest in the Solid Biosciences (SLDB) from India.

With INDmoney, you can buy Solid Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Solid Biosciences at zero transaction cost.

How can I buy Solid Biosciences shares from India?

It is very easy to buy Solid Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Solid Biosciences (SLDB) be purchased?

Yes, you can buy fractional shares of Solid Biosciences with INDmoney app.

What are the documents required to start investing in Solid Biosciences stocks?

To start investing in Solid Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Solid Biosciences Stock (SLDB)?

Today’s highest price of Solid Biosciences (SLDB) is $5.77.

Today’s lowest price of Solid Biosciences (SLDB) is $5.23.

What is today's market capitalisation of Solid Biosciences?

Today's market capitalisation of Solid Biosciences SLDB is 439.6M

What is the 52 Week High and Low Range of Solid Biosciences Stock (SLDB)?

  • 52 Week High

    $15.05

  • 52 Week Low

    $2.88

What are the historical returns of Solid Biosciences (SLDB)?

  • 1 Month Returns

    89.47%

  • 3 Months Returns

    -32.31%

  • 1 Year Returns

    -38.85%

  • 5 Years Returns

    -88.43%

Who is the Chief Executive Officer (CEO) of Solid Biosciences ?

Mr. Alexander G. Cumbo is the current Chief Executive Officer (CEO) of Solid Biosciences.